相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Role of protein kinase A and class II phosphatidylinositol 3-kinase C2β in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide
Ju Yeon Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Ion Channels in Innate and Adaptive Immunity
Stefan Feske et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts
Ju Yeon Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Increased glycolipid storage produced by the inheritance of a complex intronic haplotype in the α-galactosidase A (GLA) gene
Javier Gervas-Arruga et al.
BMC GENETICS (2015)
Pharmacological gating modulation of small- and intermediate-conductance Ca2+-activated K+ channels (KCa2.x and KCa3.1)
Palle Christophersen et al.
CHANNELS (2015)
KCa3.1: a new player in progressive kidney disease
Chunling Huang et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Functional Role of the KCa3.1 Potassium Channel in Synovial Fibroblasts From Rheumatoid Arthritis Patients
Kristin Friebel et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Characterization of monocyte/macrophage KCa3.1 channels in Gaucher disease
Aida Olivan-Viguera et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Human lung myofibroblast TGF beta 1-dependent Smad2/3 signalling is Ca2+-dependent and regulated by K(Ca)3.1 K+ channels
Katy M. Roach et al.
FIBROGENESIS & TISSUE REPAIR (2015)
A Novel Pan-Negative-Gating Modulator of KCa2/3 Channels, Fluoro-Di-Benzoate, RA-2, Inhibits Endothelium-Derived Hyperpolarization-Type Relaxation in Coronary Artery and Produces Bradycardia In Vivo
Aida Olivan-Viguera et al.
MOLECULAR PHARMACOLOGY (2015)
Globotriaosylceramide Induces Lysosomal Degradation of Endothelial KCa3.1 in Fabry Disease
Shinkyu Choi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Modulation of KCa3.1 Channels by Eicosanoids, Omega-3 Fatty Acids, and Molecular Determinants
Michael Kacik et al.
PLOS ONE (2014)
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
Clara M. Yates et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent
Katy M. Roach et al.
RESPIRATORY RESEARCH (2014)
New Positive Ca2+-Activated K+ Channel Gating Modulators with Selectivity for KCa3.1
Nichole Coleman et al.
MOLECULAR PHARMACOLOGY (2014)
Alterations of N-3 Polyunsaturated Fatty Acid-Activated K2P Channels in Hypoxia-Induced Pulmonary Hypertension
Gorm Nielsen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Endothelial Small-Conductance and Intermediate-Conductance KCa Channels: An Update on Their Pharmacology and Usefulness as Cardiovascular Targets
Heike Wulff et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Novel Phenolic Inhibitors of Small/IntermediateConductance Ca2+-Activated K+ Channels, KCa3.1 and KCa2.3
Aida Olivan-Viguera et al.
PLOS ONE (2013)
The K+ Channel KCa3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
Katy Morgan Roach et al.
PLOS ONE (2013)
Polyunsaturated fatty acids in multiple sclerosis therapy
S. Wergeland et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Comparison of growth, serum biochemistries and n-6 fatty acid metabolism in rats fed diets supplemented with high-gamma-linolenic acid safflower oil or borage oil for 90 days
Patrick Tso et al.
FOOD AND CHEMICAL TOXICOLOGY (2012)
Effects of n-3 polyunsaturated fatty acids on cardiac ion channels
Cristina Moreno et al.
FRONTIERS IN PHYSIOLOGY (2012)
Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review
Gary J. Macfarlane et al.
RHEUMATOLOGY (2011)
Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a New Activator of KCa2 and KCa3.1 Potassium Channels, Potentiates the Endothelium-Derived Hyperpolarizing Factor Response and Lowers Blood Pressure
Ananthakrishnan Sankaranarayanan et al.
MOLECULAR PHARMACOLOGY (2009)
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data
J. M. Ruijter et al.
NUCLEIC ACIDS RESEARCH (2009)
K+ channel modulators for the treatment of neurological disorders and autoimmune diseases
Heike Wulff et al.
CHEMICAL REVIEWS (2008)
Argan oil: Occurrence, composition and impact on human health
Zoubida Charrouf et al.
EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY (2008)
International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels
AD Wei et al.
PHARMACOLOGICAL REVIEWS (2005)
Molecular localization of the inhibitory arachidonic acid binding site to the pore of hIK1
KL Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1:: A potential immunosuppressant
H Wulff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)